BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38591855)

  • 1. Osteosarcoma cell death induced by innovative scaffolds doped with chemotherapeutics.
    Lanzillotti C; Iaquinta MR; De Pace R; Mosaico M; Patergnani S; Giorgi C; Tavoni M; Dapporto M; Sprio S; Tampieri A; Montesi M; Martini F; Mazzoni E
    J Cell Physiol; 2024 May; 239(5):e31256. PubMed ID: 38591855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
    Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
    Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A novel tissue-engineered bone constructed by using human adipose-derived stem cells and biomimetic calcium phosphate scaffold coprecipitated with bone morphogenetic protein-2].
    Jiang WR; Zhang X; Liu YS; Wu G; Ge YJ; Zhou YS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Feb; 49(1):6-15. PubMed ID: 28202997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strontium(II) and mechanical loading additively augment bone formation in calcium phosphate scaffolds.
    Reitmaier S; Kovtun A; Schuelke J; Kanter B; Lemm M; Hoess A; Heinemann S; Nies B; Ignatius A
    J Orthop Res; 2018 Jan; 36(1):106-117. PubMed ID: 28574614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium phosphate-phosphorylated adenosine hybrid microspheres for anti-osteosarcoma drug delivery and osteogenic differentiation.
    Zhou ZF; Sun TW; Chen F; Zuo DQ; Wang HS; Hua YQ; Cai ZD; Tan J
    Biomaterials; 2017 Mar; 121():1-14. PubMed ID: 28063979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Mesoporous Calcium Sillicate/Chitosan Porous Scaffolds for Enhanced Bone Regeneration and Photothermal-Chemotherapy of Osteosarcoma.
    Yang F; Lu J; Ke Q; Peng X; Guo Y; Xie X
    Sci Rep; 2018 May; 8(1):7345. PubMed ID: 29743489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis.
    Schumacher M; Wagner AS; Kokesch-Himmelreich J; Bernhardt A; Rohnke M; Wenisch S; Gelinsky M
    Acta Biomater; 2016 Jun; 37():184-94. PubMed ID: 27084107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents.
    Sun J; Fu ZM; Fang CQ; Li JH
    Chin Med J (Engl); 2007 Mar; 120(5):400-4. PubMed ID: 17376311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma.
    Li W; Zhang X; Xi X; Li Y; Quan H; Liu S; Wu L; Wu P; Lan W; Shao Y; Li H; Chen K; Hu Z
    Cancer Med; 2020 Jun; 9(12):4371-4385. PubMed ID: 32349184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal short-chain C6 ceramide induces potent anti-osteosarcoma activity in vitro and in vivo.
    Zhai L; Sun N; Han Z; Jin HC; Zhang B
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):274-80. PubMed ID: 26505795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression.
    Zhou Y; Zhao RH; Tseng KF; Li KP; Lu ZG; Liu Y; Han K; Gan ZH; Lin SC; Hu HY; Min DL
    Acta Pharmacol Sin; 2016 Apr; 37(4):519-29. PubMed ID: 26924291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
    Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
    Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LY294002 suppresses the malignant phenotype and sensitizes osteosarcoma cells to pirarubicin chemotherapy.
    Long XH; Zhong ZH; Peng AF; Zhu LB; Wang H; Zhang GM; Liu ZL
    Mol Med Rep; 2014 Dec; 10(6):2967-72. PubMed ID: 25310590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinational delivery of anticancer drugs for osteosarcoma treatment using electrosprayed core shell nanocarriers.
    Prasad SR; Jayakrishnan A; Kumar TSS
    J Mater Sci Mater Med; 2020 May; 31(5):44. PubMed ID: 32367204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics.
    Engert F; Kovac M; Baumhoer D; Nathrath M; Fulda S
    Oncotarget; 2017 Jul; 8(30):48794-48806. PubMed ID: 27447864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a doxorubicin-loaded bioinspired bone cement for the localized treatment of osteosarcoma.
    Martinez T; Sarda S; Dupret-Bories A; Charvillat C; Projetti F; Drouet C
    Future Oncol; 2021 Sep; 17(26):3511-3528. PubMed ID: 34213375
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
    Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
    Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC inhibitor-loaded bone cement for advanced local treatment of osteosarcoma and chondrosarcoma.
    Tonak M; Becker M; Graf C; Eckhard L; Theobald M; Rommens PM; Wehler TC; Proschek D
    Anticancer Res; 2014 Nov; 34(11):6459-66. PubMed ID: 25368246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines.
    Thompson L; Wang S; Tawfik O; Templeton K; Tancabelic J; Pinson D; Anderson HC; Keighley J; Garimella R
    J Orthop Res; 2012 May; 30(5):831-44. PubMed ID: 22042758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of adriamycin gelatin microsphere-loaded decellularized periosteum that is cytotoxic to human osteosarcoma cells.
    Chen C; Dong J; Chen H; Wang X; Mei J; Wang L; Xian CJ
    J Cell Physiol; 2019 Jul; 234(7):10771-10781. PubMed ID: 30480804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.